Category Archives: News & updates

More patients with serious psychological distress had insurance coverage following the Affordable Care Act, but that didn’t change whether they’d seen a healthcare professional recently, researchers reported. In an analysis of data from the National Health Interview Survey (NHIS), the … Continue reading →

WASHINGTON — The atypical antipsychotic drug aripiprazole (Abilify, Abilify Maintena, Aristada) may trigger loss of impulse control, leading to “compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex,” the FDA warned Tuesday. New warnings will be added … Continue reading →

Repeated infusions of ketamine “rapidly and robustly” decreased chronic thoughts of suicide in half of patients with treatment-resistant depression, secondary analysis from a preliminary open-label study showed. At the end of the series of infusions, 7 out of 14 patients … Continue reading →

Lithium was more effective than other maintenance monotherapies in reducing impulsive aggression and the tendency of patients with bipolar disorder to inflict self-harm and unintentional injury, a longitudinal cohort study showed. In addition, self-harm rates in those prescribed valproate were … Continue reading →

Despite much more insurance coverage than in the past, patients with behavioral health needs are not getting the treatment they need, according to a recent study. The Patient Protection and Affordable Care Act (PPACA) was supposed to improve access to … Continue reading →